Month: April 2019
-
Engineered Moth to Control Soybean Pest
A company providing genetically engineered insects to control threats to health and agriculture is designing a modified moth that now destroys soybeans and other crops.
-
Human Heart 3-D Printed from Patient Cells
A biomedical engineering team printed a three-dimensional scale model of a human heart, including blood vessels, from cells donated by a living person.
-
Start-Up Analyzes Images to Determine Medical Condition
A new company provides a service that determines a person’s condition for disease treatments based on indicators derived from an analysis of huge medical-image databases.
-
Univ-Business Consortium Developing Advanced Satellites
An international consortium, led by University of South Australia, plans to create a new generation of space satellites with greater sensing and communications capabilities.
-
New on Medium – Guide to Demystify A.I.
I decided to share reporting tips on A.I. with fellow journalists to help make the algorithms in our lives more understandable to lay readers.
-
Infographic – Venture Deals Cool Off in Q1 2019
Venture capital investments worldwide declined in the first quarter of 2019, compared to the near record-setting pace of the last 3 months of 2018.
-
Lung Model Developed to Test E-Cigarettes, Hookah
A three-dimensional model of a human lung is being developed to test health effects of new trends in smoking, such as electronic cigarettes and hookahs.
-
Resistant Fungus Treatment Shown Effective in Early Results
Results from a clinical trial show an experimental anti-fungal drug effective in 2 cases of Candida auris infections, a fungus resistant to most other drugs.
-
Smartwatch Monitor Boosts Parkinson’s Care
A university in the U.K. designed a home-based care plan for people with Parkinson’s disease that uses a smartwatch device to monitor their conditions.
-
FDA Expands Evidence Project to Replace Trials
The Food and Drug Administration is expanding a demonstration project with a Boston teaching hospital that tests the value of real world evidence to replace some clinical trials.